General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-13 | 2024-03 | -0.61 | N/A | N/A | N/A |
2024-02-28 | 2023-12 | -0.44 | -0.47 | -0.03 | -6.82% |
2023-11-08 | 2023-09 | -0.46 | -0.4 | 0.06 | 13.04% |
2023-11-08 | 2023-09 | -0.46 | N/A | N/A | N/A |
2023-08-08 | 2023-06 | -0.47 | -0.34 | 0.13 | 27.66% |
2023-08-08 | 2023-06 | -0.47 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | JP Morgan | Downgrade | Neutral | Underweight |
2023-03-15 | JP Morgan | Upgrade | Neutral | |
2023-01-26 | SVB Leerink | Upgrade | Market Perform | |
2023-01-23 | Morgan Stanley | Upgrade | Underweight | |
2022-08-14 | Morgan Stanley | Upgrade | Underweight | |
2022-03-01 | JP Morgan | Upgrade | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-11-13 | BERGER FRANKLIN MILAN | Director | 778.35K | Sale |
2024-01-31 | CORCORAN ANDREA J | Chief Financial Officer | 670.21K | Sale |
2024-01-31 | FOSTER WAYNE CPA | Officer | 20.86K | Sale |
2020-11-02 | HACK ANDREW A. F. | Director | 0.00 | Purchase |
2024-01-31 | HAMMOND JANET MJ | Officer | 35.36K | Sale |
2024-01-31 | HORGA MARIA ARANTXA | Officer | 25.66K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | FMR, LLC | 8.50M | 31.78M | 10.19% |
2023-06-29 | Blackrock Inc. | 7.71M | 28.83M | 9.24% |
2023-06-29 | EcoR1 Capital, LLC | 7.00M | 26.16M | 8.39% |
2023-06-29 | Vanguard Group Inc | 4.52M | 16.90M | 5.42% |
2023-06-29 | Tang Capital Management, LLC | 3.03M | 11.32M | 3.63% |
2023-06-29 | Bain Capital Life Sciences Investors, LLC | 2.49M | 9.30M | 2.98% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.25M | 8.43M | 2.70% |
2023-08-30 | Fidelity Growth Company Fund | 1.99M | 6.69M | 2.39% |
2023-08-30 | iShares Russell 2000 ETF | 1.74M | 5.84M | 2.08% |
2023-05-30 | Fidelity Growth Company K6 Fund | 1.18M | 4.71M | 1.42% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.17M | 4.36M | 1.40% |
2023-08-30 | iShares Russell 2000 Value ETF | 691.44K | 2.32M | 0.83% |
Shorts and hedge fund boys cleaning up on this one drowning it
Wow this one sinking like titanic
$AVIR I JUST BOUGHT IN. LIKE THE POTENTIAL, BUT BRING PROFITS TO $ATER OR CEI! IMMINENT SQUEEZE COMING! SPREAD THE WEALTH. KEEP UP THE KARMA! You’re welcome folks
$AVIR how do you put a PT on the cure for covid?
$AVIR running as its ALREADY been shown to be more effective than mercks antiviral
$AVIR just the start. The cure for covid, so PTs are useless
$AVIR dip n rip. Best r/r stock out there rn
$AVIR cure for covid in pill form. This will run and run
$AVIR this will be the one all week, esp in this kinda market. Where else are u putting your money if not in the cure for covid?
$AVIR this will be hot this week
Dave is rich! 5k shares...
You can go to Reddit, but I don’t think you can change anything...
Please cut more... want to buy at 18 again
Everyone sold...no...wait and buy more
Strong sold~
I see they still have 25 million deffered revenue and will be booked in this year. 18 is a good price to buy